The effect of pidotimod combined photodynamic therapy on Langerhans cells in female patients with condyloma acuminate

Xu ZHENG,Wei JIANG,Jian-ming GAO
DOI: https://doi.org/10.3969/j.issn.1671-4695.2018.08.026
2018-01-01
Abstract:Objective To explore the effect of pidotimod combined photodynamic therapy (PDT) on Langerhans cells in female patients with condyloma acuminata (CA). Methods One hundred female patients with CA were selected from the department of dermatology of this hospital during June 2013 to June 2016, and they were divided into pi light group and single light group according to the random number table method,50cases in each group. Patients in single light group were given with 5-aminolevulinic acid photodynamic therapy (PDT) for treatment, and patients in pi light group were given with pidotimod on the basis of treatment in single light group,and immune functions were compared before and after the treatment, LC and effect of treatment and recurrence rate were compared between these two groups. Results Amount of CD3 +,CD4+, CD4+/CD8+ and number of LC,and density of positive cells in pi light group were significantly higher than those of single light group, and the number of CD8+ in pi ligt group was significantly lower than those of single light group, and the difference was statistically significant (P<0.05). The therapeutic response rate of pi light group was 96.00%, it was significantly higher than those (84.00%) of single light group, and the difference was statistically significant (P<0.05). The rates of adverse reactions in pi light group and single light group were 22.00% and 18.00% respectively, and the difference was not statistically significant (P>0.05). After follow-up for 12months, the recurrence rate of pi light group was 6.25%, it was significantly lower than that (23.81%) of single light group, and the difference was statistically significant (P<0.05), Conclusion The application of pidotimod combined photodynamic therapy can effectively improve the immune function of female patients with CA, it may facilitate the promotion of recovery of Langerhans' cells to improve the curative effect and reduce the recurrence, hence it is worthy to be further clinically promoted.
What problem does this paper attempt to address?